H. Boom

Developing aerosol vaccines for Mycobacterium tuberculosis: Workshop proceedings: National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, April 9, 2014.

W. Hanekom, A. Hickey, R. Seder, 2015, Vaccine.

Introduction of an in-house PCR for routine identification of M. tuberculosis in a low-income country.

K. Eisenach, R. Mugerwa, M. Joloba, 2006, The International Journal of Tuberculosis and Lung Disease.

Innate Immunity and APC Function Lipoprotein Agonist of TLR2 That Regulates LprA Is a Mycobacterium tuberculosis

C. Harding, A. Gehring, N. Pecora, 2006 .

Long-term dominance of Mycobacterium tuberculosis Uganda family in peri-urban Kampala-Uganda is not associated with cavitary disease

G. Kaplan, M. Nsereko, E. Mupere, 2013, BMC Infectious Diseases.

Rhomboid homologs in mycobacteria: insights from phylogeny and genomic analysis

M. Joloba, K. Eisenach, D. Kateete, 2010, BMC Microbiology.

Bacterial Factors That Predict Relapse after Tuberculosis Therapy

John L. Johnson, D. Sherman, Aditi Gupta, 2018, The New England journal of medicine.

Four‐Gene Pan‐African Blood Signature Predicts Progression to Tuberculosis

Daniel E. Zak, Fergal J. Duffy, D. Zak, 2018, American journal of respiratory and critical care medicine.

What is the most reliable solid culture medium for tuberculosis treatment trials?

John L. Johnson, M. Joloba, C. Heilig, 2014, Tuberculosis.